Fiorenzo Gaita

Author PubWeight™ 122.71‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation 2003 3.68
2 Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study. J Am Coll Cardiol 2012 3.18
3 Short QT syndrome: clinical findings and diagnostic-therapeutic implications. Eur Heart J 2006 2.59
4 Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 2003 2.56
5 Electromechanical coupling in patients with the short QT syndrome: further insights into the mechanoelectrical hypothesis of the U wave. Heart Rhythm 2007 2.44
6 Cardiac remote ischaemic preconditioning reduces periprocedural myocardial infarction for patients undergoing percutaneous coronary interventions: a meta-analysis of randomised clinical trials. EuroIntervention 2014 2.30
7 Adjusted indirect comparison meta-analysis of prasugrel versus ticagrelor for patients with acute coronary syndromes. Int J Cardiol 2010 2.23
8 Coronary computed tomographic angiography for detection of coronary artery disease in patients presenting to the emergency department with chest pain: a meta-analysis of randomized clinical trials. Eur Heart J Cardiovasc Imaging 2012 2.19
9 Unresolved issues in transcatheter atrial fibrillation ablation: silent cerebrovascular ischemias. J Cardiovasc Electrophysiol 2012 1.98
10 Further insights into the effect of quinidine in short QT syndrome caused by a mutation in HERG. J Cardiovasc Electrophysiol 2005 1.74
11 Morphologic analysis of left atrial anatomy by magnetic resonance angiography in patients with atrial fibrillation: a large single center experience. J Cardiovasc Electrophysiol 2011 1.66
12 Risk stratification of the patients with Brugada type electrocardiogram: a community-based prospective study. Europace 2009 1.66
13 Atherosclerotic coronary plaque regression and the risk of adverse cardiovascular events: a meta-regression of randomized clinical trials. Atherosclerosis 2012 1.63
14 Long-term efficacy and safety of two different rhythm control strategies in elderly patients with symptomatic persistent atrial fibrillation. J Cardiovasc Electrophysiol 2013 1.60
15 Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients: evidence from a 37,229 patient meta-analysis. Am Heart J 2011 1.59
16 Can spinal cord stimulation reduce ventricular arrhythmias? Heart Rhythm 2012 1.46
17 Impact of TAVI on mitral regurgitation: a prospective echocardiographic study. Echocardiography 2012 1.44
18 Intracardiac impedance monitors stroke volume in resynchronization therapy patients. Europace 2010 1.43
19 Patent foramen ovale treatment strategy: an Italian large prospective study. J Cardiovasc Med (Hagerstown) 2014 1.41
20 [Doubts of the cardiologist regarding an electrocardiogram presenting QRS V1-V2 complexes with positive terminal wave and ST segment elevation. Consensus Conference promoted by the Italian Cardiology Society]. G Ital Cardiol (Rome) 2010 1.41
21 Long-term follow-up of patients with short QT syndrome. J Am Coll Cardiol 2011 1.29
22 TIMI, GRACE and alternative risk scores in Acute Coronary Syndromes: a meta-analysis of 40 derivation studies on 216,552 patients and of 42 validation studies on 31,625 patients. Contemp Clin Trials 2012 1.26
23 Acute coronary syndromes in human immunodeficiency virus patients: a meta-analysis investigating adverse event rates and the role of antiretroviral therapy. Eur Heart J 2011 1.26
24 Short QT syndrome. Cardiovasc Res 2005 1.21
25 Ablation of atrial fibrillation: does the addition of three-dimensional magnetic resonance imaging of the left atrium to electroanatomic mapping improve the clinical outcome?: a randomized comparison of Carto-Merge vs. Carto-XP three-dimensional mapping ablation in patients with paroxysmal and persistent atrial fibrillation. Europace 2010 1.20
26 Reduced fluoroscopy exposure during ablation of atrial fibrillation using a novel electroanatomical navigation system: a multicentre experience. Europace 2011 1.20
27 Short QT syndrome: successful prevention of sudden cardiac death in an adolescent by implantable cardioverter-defibrillator treatment for primary prophylaxis. Heart Rhythm 2005 1.17
28 Short QT syndrome. Genotype-phenotype correlations. J Electrocardiol 2005 1.11
29 Risk stratification in individuals with the Brugada type 1 ECG pattern without previous cardiac arrest: usefulness of a combined clinical and electrophysiologic approach. Eur Heart J 2010 1.10
30 Incidence, etiology and predictors of adverse outcomes in 43,315 patients presenting to the Emergency Department with syncope: an international meta-analysis. Int J Cardiol 2011 1.04
31 Comparison of ThermoCool® Surround Flow catheter versus ThermoCool® catheter in achieving persistent electrical isolation of pulmonary veins: a pilot study. J Cardiovasc Electrophysiol 2012 1.03
32 Comparison of mortality rates in women versus men presenting with ST-segment elevation myocardial infarction. Am J Cardiol 2010 1.02
33 Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses. Int J Cardiol 2012 1.01
34 Atrial fibrillation termination as a procedural endpoint during ablation in long-standing persistent atrial fibrillation. Heart Rhythm 2010 1.00
35 Clinical characteristics and treatment of short QT syndrome. Expert Rev Cardiovasc Ther 2005 0.99
36 Remote ischaemic preconditioning in coronary artery bypass surgery: a meta-analysis. Heart 2012 0.99
37 Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: a meta-analysis in the highly active antiretroviral therapy era. Eur Heart J 2013 0.98
38 Impact of ablation catheter irrigation design on silent cerebral embolism after radiofrequency catheter ablation of atrial fibrillation: results from a pilot study. J Cardiovasc Electrophysiol 2012 0.98
39 In vivo effects of mutant HERG K+ channel inhibition by disopyramide in patients with a short QT-1 syndrome: a pilot study. J Cardiovasc Electrophysiol 2007 0.96
40 Prevalence and non-invasive predictors of left main or three-vessel coronary disease: evidence from a collaborative international meta-analysis including 22 740 patients. Heart 2012 0.96
41 Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression. Europace 2010 0.94
42 International collaborative systematic review of controlled clinical trials on pharmacologic treatments for acute pericarditis and its recurrences. Am Heart J 2010 0.94
43 Typical atrial flutter ablation outcome: correlation with isthmus anatomy using intracardiac echo 3D reconstruction. Europace 2004 0.93
44 A method for quantifying atrial fibrillation organization based on wave-morphology similarity. IEEE Trans Biomed Eng 2002 0.92
45 Visualization of multiple catheters with electroanatomical mapping reduces X-ray exposure during atrial fibrillation ablation. Europace 2011 0.91
46 Silent cerebral events/lesions related to atrial fibrillation ablation: a clinical review. J Cardiovasc Electrophysiol 2015 0.91
47 Atrial fibrillation requiring urgent medical care. Approach and outcome in the various departments of admission. Data from the atrial Fibrillation/flutter Italian REgistry (FIRE). Ital Heart J 2004 0.91
48 Differences in twelve-lead electrocardiogram between symptomatic and asymptomatic subjects with short QT interval. Heart Rhythm 2008 0.89
49 Percutaneous catheter cryothermal ablation of atrioventricular nodal reentrant tachycardia: efficacy and safety of a new ablation technique. Ital Heart J 2003 0.89
50 A new electrophysiology era: zero fluoroscopy. J Cardiovasc Med (Hagerstown) 2013 0.89
51 Tachycardia-induced cardiomyopathy: mechanisms of heart failure and clinical implications. J Cardiovasc Med (Hagerstown) 2007 0.88
52 Single center experience of fluoroless AVNRT ablation guided by electroanatomic reconstruction in children and adolescents. Pacing Clin Electrophysiol 2013 0.87
53 Thirty-day readmission rates after PCI in a metropolitan center in Europe: incidence and impact on prognosis. J Cardiovasc Med (Hagerstown) 2015 0.86
54 Echo Doppler predictors of pulmonary artery hypertension in patients with systemic sclerosis. Echocardiography 2011 0.86
55 Left atrial volume at MRI is the main determinant of outcome after pulmonary vein isolation plus linear lesion ablation for paroxysmal-persistent atrial fibrillation. J Cardiovasc Med (Hagerstown) 2010 0.85
56 Gender differences in patients undergoing TAVI: a multicentre study. EuroIntervention 2013 0.85
57 Takotsubo cardiomyopathy as a complication of pacemaker implantation. J Cardiovasc Med (Hagerstown) 2011 0.84
58 Is acquired short QT due to digitalis intoxication responsible for malignant ventricular arrhythmias? J Electrocardiol 2006 0.84
59 Short QT syndrome. Update on a recent entity. Arch Cardiovasc Dis 2008 0.83
60 Resynchronization therapy optimization by intracardiac impedance. Europace 2010 0.83
61 Inaccuracy of available surgical risk scores to predict outcomes after transcatheter aortic valve replacement. J Cardiovasc Med (Hagerstown) 2013 0.83
62 Pulmonary vein isolation with a new multipolar irrigated radiofrequency ablation catheter (nMARQ™): feasibility, acute and short-term efficacy, safety, and impact on postablation silent cerebral ischemia. J Cardiovasc Electrophysiol 2014 0.83
63 Long-term results of transcatheter atrial fibrillation ablation in patients with impaired left ventricular systolic function. J Cardiovasc Electrophysiol 2012 0.83
64 A meta-analysis of sex-related differences in outcomes after primary percutaneous intervention for ST-segment elevation myocardial infarction. J Interv Cardiol 2015 0.83
65 Relationship of ECG findings to phenotypic expression in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance study. Int J Cardiol 2012 0.82
66 Slow pathway ablation for atrioventricular nodal reentry. J Cardiovasc Electrophysiol 2002 0.82
67 Pulmonary veins branching pattern, assessed by magnetic resonance, does not affect transcatheter atrial fibrillation ablation outcome. Acta Cardiol 2010 0.81
68 Early EPS/ICD strategy in survivors of acute myocardial infarction with severe left ventricular dysfunction on optimal beta-blocker treatment. The BEta-blocker STrategy plus ICD trial. Europace 2005 0.81
69 Echocardiographic evaluation of right ventricular stroke work index in advanced heart failure: a new index? J Card Fail 2012 0.81
70 Impact of postdilatation on performance of bioresorbable vascular scaffolds in patients with acute coronary syndrome compared with everolimus-eluting stents: A propensity score-matched analysis from a multicenter "real-world" registry. Cardiol J 2016 0.81
71 Wave similarity mapping shows the spatiotemporal distribution of fibrillatory wave complexity in the human right atrium during paroxysmal and chronic atrial fibrillation. J Cardiovasc Electrophysiol 2005 0.81
72 Impact of access on TAVI procedural and midterm follow-up: a meta-analysis of 13 studies and 10,468 patients. J Interv Cardiol 2014 0.80
73 The EUROpean and Chinese cardiac and renal Remote Ischemic Preconditioning Study (EURO-CRIPS): study design and methods. J Cardiovasc Med (Hagerstown) 2015 0.80
74 Percutaneous coronary intervention in nonagenarian: a meta-analysis of observational studies. J Cardiovasc Med (Hagerstown) 2013 0.80
75 Diagnostic accuracy of a new software for complex fractionated electrograms identification in patients with persistent and permanent atrial fibrillation. J Cardiovasc Electrophysiol 2008 0.80
76 Berberine behind the thriller of marked symptomatic bradycardia. World J Cardiol 2013 0.80
77 Late gadolinium enhancement on cardiac magnetic resonance and phenotypic expression in hypertrophic cardiomyopathy. Am Heart J 2011 0.80
78 Telomere length variation in juvenile acute myocardial infarction. PLoS One 2012 0.80
79 Diffuse coronary disease: short- and long-term outcome after percutaneous coronary intervention. Acta Cardiol 2013 0.80
80 Retrospective multicenter observational study of the interventional management of coronary disease in the very elderly: the NINETY. Catheter Cardiovasc Interv 2013 0.80
81 30 days and midterm outcomes of patients undergoing percutaneous replacement of aortic valve according to their renal function: a multicenter study. Int J Cardiol 2012 0.80
82 Prevalence of supraventricular tachyarrhythmias in a cohort of 115 patients with Brugada syndrome. Ann Noninvasive Electrocardiol 2008 0.80
83 One-year follow-up of conduction disturbances following transcatheter aortic valve implantation. J Cardiovasc Med (Hagerstown) 2015 0.80
84 Functional and echocardiographic improvement following multisite biventricular pacing for congestive heart failure. Can J Cardiol 2003 0.79
85 Local electrogram assessment of unidirectional isthmus block is sufficient to predict the acute and long-term success of cavo-tricuspid isthmus ablation. Ital Heart J 2002 0.79
86 Acute coronary syndrome in HIV patients: from pathophysiology to clinical practice. Cardiovasc Diagn Ther 2012 0.79
87 Antiplatelet combinations for prevention of atherothrombotic events. Vasc Health Risk Manag 2011 0.79
88 Use of oral gadobenate dimeglumine to visualise the oesophagus during magnetic resonance angiography in patients with atrial fibrillation prior to catheter ablation. J Cardiovasc Magn Reson 2014 0.79
89 Discontinuation of dual antiplatelet therapy over 12 months after acute coronary syndromes increases risk for adverse events in patients treated with percutaneous coronary intervention: systematic review and meta-analysis. J Interv Cardiol 2014 0.78
90 Clinical, electrocardiographic, echocardiographic characteristics and long-term follow-up of elite soccer players with J-point elevation. Circ Arrhythm Electrophysiol 2013 0.78
91 BleeMACS: rationale and design of the study. J Cardiovasc Med (Hagerstown) 2016 0.78
92 Long-term events following atrial fibrillation rate control or transcatheter ablation: a multicenter observational study. J Cardiovasc Med (Hagerstown) 2016 0.78
93 Lead vegetations in patients with local and systemic cardiac device infections: prevalence, risk factors, and therapeutic effects. Europace 2012 0.78
94 Symptomatic and asymptomatic long-term recurrences following transcatheter atrial fibrillation ablation. Pacing Clin Electrophysiol 2014 0.78
95 Isolated noncompaction of the right ventricular myocardium in the adulthood? Int J Cardiol 2008 0.78
96 Impact on prognosis of periprocedural bleeding after TAVI: mid-term follow-up of a multicenter prospective study. J Interv Cardiol 2014 0.78
97 Use and misuse of multivariable approaches in interventional cardiology studies on drug-eluting stents: a systematic review. J Interv Cardiol 2012 0.77
98 Laboratory aspirin resistance reversibility in diabetic patients: a pilot study using different pharmaceutical formulations. Cardiovasc Drugs Ther 2014 0.77
99 Late gadolinium enhancement and sudden cardiac death in hypertrophic cardiomyopathy. J Am Coll Cardiol 2011 0.77
100 Prognostic role of myocardial performance index on long-term survival after heart transplantation: a prospective study. Echocardiography 2013 0.77
101 Cryptogenic ischemic stroke and prevalence of asymptomatic atrial fibrillation: a prospective study. J Cardiovasc Med (Hagerstown) 2016 0.77
102 T-Wave morphology in short QT syndrome. Ann Noninvasive Electrocardiol 2009 0.77
103 Alternatives to clopidogrel for acute coronary syndromes: Prasugrel or ticagrelor? World J Cardiol 2010 0.77
104 Emotional coping is a better predictor of cardiac prognosis than depression and anxiety. J Psychosom Res 2012 0.77
105 European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. Europace 2015 0.77
106 Prevalence and predictors of long corrected QT interval in HIV-positive patients: a multicenter study. J Cardiovasc Med (Hagerstown) 2017 0.77
107 A meta-analysis investigating incidence and features of stroke in HIV-infected patients in the highly active antiretroviral therapy era. J Cardiovasc Med (Hagerstown) 2015 0.76
108 Outcomes of Patients Undergoing Balloon Aortic Valvuloplasty in the TAVI Era: A Multicenter Registry. J Invasive Cardiol 2015 0.76
109 Reply: To PMID 22858289. J Am Coll Cardiol 2013 0.76
110 Intravenous human immunoglobulins for refractory recurrent pericarditis: a systematic review of all published cases. J Cardiovasc Med (Hagerstown) 2016 0.76
111 Drugs for attention deficit-hyperactivity disorder do not increase the mid-term risk of sudden death in children: a meta-analysis of observational studies. Int J Cardiol 2013 0.76
112 Heart failure in patients with human immunodeficiency virus: a review of the literature. J Cardiovasc Med (Hagerstown) 2015 0.76
113 Choosing the best first line oral drug agent in patients with pulmonary hypertension: evidence from a network meta-analysis. Int J Cardiol 2013 0.76
114 'Unexpected' sudden death avoided by implantable cardioverter defibrillator in Emery Dreifuss patient. Europace 2007 0.76
115 Lone atrial fibrillation ablation. Transcatheter or minimally invasive surgical approaches? J Am Coll Cardiol 2002 0.75
116 Pressure ulcer: an unreported complication of the Safeguard® hemostasis device. No need to crack under pressure. Heart Int 2011 0.75
117 Changing of SYNTAX score performing fractional flow reserve in multivessel coronary artery disease. J Cardiovasc Med (Hagerstown) 2012 0.75
118 Meta-analysis of coronary CT angiography in the emergency department: reply. Eur Heart J Cardiovasc Imaging 2013 0.75
119 Silent cerebrovascular ischemias following transcatheter atrial fibrillation ablation: definition and cerebral magnetic resonance protocols. J Cardiovasc Electrophysiol 2013 0.75
120 To the editor. J Cardiovasc Electrophysiol 2011 0.75
121 Reply: Can silent brain lesions be a target to guide anticoagulation treatment in patients with low-risk atrial fibrillation to reduce cognitive impairment? J Am Coll Cardiol 2014 0.75
122 Detection of anticonductive tissue autoantibodies in a patient with chronic intestinal pseudo-obstruction and sick sinus syndrome. Eur J Gastroenterol Hepatol 2013 0.75
123 Delaying cardioversion following 4-week anticoagulation in case of persistent atrial fibrillation after a transcatheter ablation procedure to reduce silent cerebral thromboembolism: a single-center pilot study. J Cardiovasc Med (Hagerstown) 2011 0.75
124 Cryoablation of the left posterior atrial wall: 95 patients and 3 years of mean follow-up. Eur J Cardiothorac Surg 2003 0.75
125 A right ventricular outflow tract focus triggering tachycardiomyopathy in a peripartum patient exposed to radiation and chemotherapy. J Cardiovasc Med (Hagerstown) 2017 0.75
126 Electrical cardioversion of persistent atrial fibrillation: acute and long-term results stratified according to arrhythmia duration. Pacing Clin Electrophysiol 2012 0.75
127 The heart in an airbag: spontaneous pneumopericardium in a young lady. J Cardiovasc Med (Hagerstown) 2012 0.75
128 Drug abuse: another challenge for the cardiologist? J Cardiovasc Med (Hagerstown) 2014 0.75
129 [Radiofrequency catheter ablation of atrial fibrillation: how it has changed since 1996]. G Ital Cardiol (Rome) 2012 0.75
130 History of transcatheter atrial fibrillation ablation. J Cardiovasc Med (Hagerstown) 2012 0.75
131 [The PALLAS study]. G Ital Cardiol (Rome) 2012 0.75
132 Angiographic Follow-Up in Patients With Coronary Artery Disease: Is There a Window to Be Definitively Closed? JACC Cardiovasc Interv 2017 0.75
133 What is the optimal treatment for symptomatic patients with isolated coronary myocardial bridge? A systematic review and pooled analysis. J Cardiovasc Med (Hagerstown) 2017 0.75
134 Melanoma metastasis over a pacemaker pocket: integrated management strategies and facilitating factors. Europace 2013 0.75
135 Complete or incomplete coronary revascularization in patients with myocardial infarction and multivessel disease. A propensity score analysis from the "real life" BleeMACS (Bleeding complications in a Multicenter registry of patients discharged with diagnosis of Acute Coronary Syndrome) registry. EuroIntervention 2017 0.75
136 [The EMBRACE study]. G Ital Cardiol (Rome) 2015 0.75
137 Anatomic relationship between left coronary artery and left atrium in patients undergoing atrial fibrillation ablation. J Cardiovasc Med (Hagerstown) 2016 0.75
138 Atrial tachycardia as a proarrhythmic effect of radiofrequency catheter ablation for atrioventricular nodal reentrant tachycardia. Pacing Clin Electrophysiol 2011 0.75
139 Impact of targeting adenosine-induced transient venous reconnection in patients undergoing pulmonary vein isolation for atrial fibrillation: a meta-analysis of 3524 patients. J Cardiovasc Med (Hagerstown) 2017 0.75
140 [Refractory heart failure. Multisite stimulation]. Ital Heart J Suppl 2002 0.75
141 Comment on the EXPLORE Trial. J Am Coll Cardiol 2017 0.75
142 Contrast-induced kidney injury: how does it affect long-term cardiac mortality? J Cardiovasc Med (Hagerstown) 2017 0.75
143 Electropharmacological effects of antiarrhythmic drugs on atrial fibrillation termination. Part II: New insights into the electrophysiological mechanisms of atrial fibrillation termination. Ital Heart J 2003 0.75
144 Analysis of extracted cardiac device leads for bacteria type: clinical impact. Expert Rev Cardiovasc Ther 2013 0.75
145 Early repolarization: an evolving concept for the past 70 years. J Cardiovasc Med (Hagerstown) 2016 0.75
146 Left Atrial Function After Radiofrequency Catheter Ablation of Atrial Fibrillation - Can Pre-Ablation Function Predict Contractile Improvement During Follow-up? Circ J 2015 0.75
147 Multimodality imaging of pericardial diseases. J Cardiovasc Med (Hagerstown) 2016 0.75
148 Percutaneous closure of atrial septal defect in adults: very long-term clinical outcome and effects on aortic and mitral valve function. J Invasive Cardiol 2015 0.75
149 Relationship between ventricular pressure and coronary artery disease in asymptomatic adult heart transplant recipients. J Cardiovasc Med (Hagerstown) 2017 0.75
150 Left persistent superior vena cava and paroxysmal atrial fibrillation: the role of selective radio-frequency transcatheter ablation. J Cardiovasc Med (Hagerstown) 2014 0.75
151 Transcatheter aortic valve implantation in low ejection fraction/low transvalvular gradient patients: the rule of 40. J Cardiovasc Med (Hagerstown) 2017 0.75
152 Percutaneous implantation of a second device in patients with residual right-to-left shunt after patent foramen ovale closure. J Interv Cardiol 2014 0.75
153 You can't judge a book by its cover: a trivial angiographic image, an optical coherence tomography run and a surprising ending. Eur Heart J 2016 0.75
154 Gram-positive occult bacteremia in patients with pacemaker and mechanical valve prosthesis: a difficult therapeutic challenge. Europace 2010 0.75
155 High sensitive TROponin levels In Patients with Chest pain and kidney disease: A multicenter registry - The TROPIC study. Cardiol J 2017 0.75
156 Arrhythmogenic right ventricular cardiomyopathy: ECG progression over time and correlation with long-term follow-up. J Cardiovasc Med (Hagerstown) 2016 0.75
157 How should I treat a patient with a proximal left anterior descending large plaque burden embolising plaque? EuroIntervention 2015 0.75
158 Do left atrial appendage morphology and function help predict thromboembolic risk in atrial fibrillation? J Cardiovasc Med (Hagerstown) 2016 0.75
159 Atrial fibrillation and female sex. J Cardiovasc Med (Hagerstown) 2015 0.75
160 Incidence, predictors, and impact on prognosis of systolic pulmonary artery pressure and its improvement after transcatheter aortic valve implantation: a multicenter registry. J Invasive Cardiol 2015 0.75
161 [Remarks on the guideline recommendations for cardioverter-defibrillator implantation for primary prevention of sudden cardiac Death in patients with severe ventricular dysfunction. Consensus Document of the Italian Association of Hospital Cardiologists (ANMCO)/Italian Society of Cardiology (SIC)/Italian Association of Arrhythmology and Cardiac Pacing (AIAC)]. G Ital Cardiol (Rome) 2013 0.75
162 [Sudden cardiac death in athletes with an apparently normal heart: the channelopathies]. G Ital Cardiol (Rome) 2008 0.75
163 Electropharmacological effects of antiarrhythmic drugs on atrial fibrillation termination. Part I: Molecular and ionic fundamentals of antiarrhythmic drug actions. Ital Heart J 2003 0.75
164 Prolonged QT interval in ST-elevation myocardial infarction: predictors and prognostic value in medium-term follow-up. J Cardiovasc Med (Hagerstown) 2016 0.75
165 Clinical assessment of hypoperfusion in acute heart failure – evergreen or antique? Circ J 2014 0.75
166 Impact on prognosis of periprocedural myocardial infarction after percutaneous coronary intervention. J Interv Cardiol 2014 0.75